Your browser doesn't support javascript.
loading
N2M2 (NOA-20) phase I/II trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed non-MGMT hypermethylated glioblastoma.
Wick, Wolfgang; Dettmer, Susan; Berberich, Anne; Kessler, Tobias; Karapanagiotou-Schenkel, Irini; Wick, Antje; Winkler, Frank; Pfaff, Elke; Brors, Benedikt; Debus, Jürgen; Unterberg, Andreas; Bendszus, Martin; Herold-Mende, Christel; Eisenmenger, Andreas; von Deimling, Andreas; Jones, David T W; Pfister, Stefan M; Sahm, Felix; Platten, Michael.
Afiliación
  • Wick W; Clinical Cooperation Unit Neuro-oncology, German Cancer Consortium (DKTK), German Cancer Research Center(DKFZ), Heidelberg, Germany.
  • Dettmer S; Department of Neurology and Neuro-oncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Berberich A; NCT Trial Center, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kessler T; Clinical Cooperation Unit Neuro-oncology, German Cancer Consortium (DKTK), German Cancer Research Center(DKFZ), Heidelberg, Germany.
  • Karapanagiotou-Schenkel I; Department of Neurology and Neuro-oncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Wick A; Clinical Cooperation Unit Neuro-oncology, German Cancer Consortium (DKTK), German Cancer Research Center(DKFZ), Heidelberg, Germany.
  • Winkler F; Department of Neurology and Neuro-oncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Pfaff E; NCT Trial Center, National Center for Tumor Diseases (NCT), German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Brors B; Department of Neurology and Neuro-oncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Debus J; Clinical Cooperation Unit Neuro-oncology, German Cancer Consortium (DKTK), German Cancer Research Center(DKFZ), Heidelberg, Germany.
  • Unterberg A; Department of Neurology and Neuro-oncology Program, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • Bendszus M; Division of Pediatric Neuro-oncology, DKFZ, German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.
  • Herold-Mende C; Department of Pediatric Oncology, Hematology, Immunology, and Pulmonology, Heidelberg University Hospital, Heidelberg, Germany.
  • Eisenmenger A; Division of Applied Bioinformatics, DKFZ, National Center for Tumor Diseases, Heidelberg University Hospital, Heidelberg, Germany.
  • von Deimling A; DKTK.
  • Jones DTW; Department of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.
  • Pfister SM; National Center for Radiation Oncology (NCRO), Heidelberg Institute for Radiation Oncology (HIRO), Heidelberg, Germany.
  • Sahm F; Clinical Cooperation Unit Radiation Oncology, DKFZ, Heidelberg, Germany.
  • Platten M; Heidelberg Ion-Beam Therapy Center (HIT), Heidelberg, Germany.
Neuro Oncol ; 21(1): 95-105, 2019 01 01.
Article en En | MEDLINE | ID: mdl-30277538
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Radioterapia / Neoplasias Encefálicas / Biomarcadores de Tumor / Glioblastoma / Metilación de ADN / Temozolomida Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Radioterapia / Neoplasias Encefálicas / Biomarcadores de Tumor / Glioblastoma / Metilación de ADN / Temozolomida Tipo de estudio: Clinical_trials / Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Alemania Pais de publicación: Reino Unido